RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @bmj_latest: Single dose targeted intraoperative radiotherapy during lumpectomy should be accessible to healthcare providers and discus…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @pash22: Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-I…
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @calaridge: Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGI…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial https://t.co/HWDy1OOeLd via @jsvaidya et al
RT @jsvaidya: When considering no-radiotherapy instead of TARGIT-IORT, patients should be informed of these data. https://t.co/dn6N2OVFPb h…
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
Short version of the main paper: https://t.co/dn6N2OVFPb (slightly modified the stock photo) https://t.co/OTUA5iBo9E
When considering no-radiotherapy instead of TARGIT-IORT, patients should be informed of these data. https://t.co/dn6N2OVFPb https://t.co/3RTMkOlvhE
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @bmj_latest: Single dose targeted intraoperative radiotherapy during lumpectomy should be accessible to healthcare providers and discus…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
RT @SorenBentzen: The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.…
The problem is that the non-inferiority of the IORT arm vs. standard-of-care EBRT within a non-inferiority margin of Δ=2.5% is due to the fact that 21% of women with high-risk features got EBRT+IORT. The TARGIT trial outcome is consistent with an effect
RT @drkevinknopf: @ErinGillespieMD @Icro_Meattini @ASCO_pubs @MylinTorres @eberger32 @HinaSaeedMD Isn't this the way to go though? @jsvaidy…
RT @Maherjane: I’ve always had niggling doubts about this ( not sure why ) but data is data - what do others think now ? @SorenBentzen @Bre…
I’ve always had niggling doubts about this ( not sure why ) but data is data - what do others think now ? @SorenBentzen @BreastDocUK @cpeedell @HannahT_85 @subatomicdoc
Open Access UCL Research: Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial - UCL Discovery https://t.co/UQWKvaWNT
@ErinGillespieMD @Icro_Meattini @ASCO_pubs @MylinTorres @eberger32 @HinaSaeedMD Isn't this the way to go though? @jsvaidya https://t.co/AcU6AdBvM7
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
Why is the NHS not rolling out this revolutionary treatment for early breast cancer across the country ? Anything that lowers the number of hospital visits in a no brainer #IORt @bmj_latest
RT @bmj_latest: Single dose targeted intraoperative radiotherapy during lumpectomy should be accessible to healthcare providers and discus…
@NHSEngland save patients mental anguish. Please offer TARGIT-IORT to eligible #breastcancer patients. 'One-off' surgery. #radiotherapy given internally during #lumpectomy operation. Save NHS & Patient 'weeks' of daily radiotherapy. Save #NHS time &
RT @bmj_latest: Single dose targeted intraoperative radiotherapy during lumpectomy should be accessible to healthcare providers and discus…
RT @bmj_latest: Single dose targeted intraoperative radiotherapy during lumpectomy should be accessible to healthcare providers and discus…
Single dose targeted intraoperative radiotherapy during lumpectomy should be accessible to healthcare providers and discussed with patients when surgery for breast cancer is being planned, concludes #BMJResearch @jsvaidya https://t.co/knVxKqNc1g
RT @weoncologists: Just Out📣at @bmj_latest Study suggests for most early #BreastCancer Single dose targeted intra-operative #radiotherapy i…
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ #iort https://t.co/NeA8HCVV2K
RT @weoncologists: Just Out📣at @bmj_latest Study suggests for most early #BreastCancer Single dose targeted intra-operative #radiotherapy i…
$ICAD - (Disclaimer-Client) -Zeiss Data- Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | The BMJ https://t.co/
RT @weoncologists: Just Out📣at @bmj_latest Study suggests for most early #BreastCancer Single dose targeted intra-operative #radiotherapy i…
RT @weoncologists: Just Out📣at @bmj_latest Study suggests for most early #BreastCancer Single dose targeted intra-operative #radiotherapy i…
RT @bmj_latest: New randomised controlled trial finds that targeted intraoperative radiotherapy has similar long term local control and can…
RT @weoncologists: Just Out📣at @bmj_latest Study suggests for most early #BreastCancer Single dose targeted intra-operative #radiotherapy i…
Just Out📣at @bmj_latest Study suggests for most early #BreastCancer Single dose targeted intra-operative #radiotherapy is associated w/about 8️⃣0️⃣% chance of avoiding conventional radiotherapy☢️ ✅fewer side effects ✅same survival #BCSM #OncoAlert 🚨 h
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
RT @bmj_latest: New randomised controlled trial finds that targeted intraoperative radiotherapy has similar long term local control and can…
RT @bmj_latest: New randomised controlled trial finds that targeted intraoperative radiotherapy has similar long term local control and can…
RT @jsvaidya: For improving #breastcancer treatment, risk-adapted single-dose radiotherapy given during lumpectomy proved to be as effectiv…
RT @bmj_latest: New randomised controlled trial finds that targeted intraoperative radiotherapy has similar long term local control and can…
RT @bmj_latest: New randomised controlled trial finds that targeted intraoperative radiotherapy has similar long term local control and can…
RT @bmj_latest: New randomised controlled trial finds that targeted intraoperative radiotherapy has similar long term local control and can…
RT @bmj_latest: New randomised controlled trial finds that targeted intraoperative radiotherapy has similar long term local control and can…
RT @bmj_latest: New randomised controlled trial finds that targeted intraoperative radiotherapy has similar long term local control and can…
New randomised controlled trial finds that targeted intraoperative radiotherapy has similar long term local control and cancer survival outcomes to whole breast radiotherapy #BMJResearch @jsvaidya https://t.co/JlxQZ4hGvG
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @cloudysnow_RO: さすがにそもそもの再発率低すぎない?5年とはいえ。 https://t.co/CCml1DUbn4
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
さすがにそもそもの再発率低すぎない?5年とはいえ。
RT @CochraneJapan: BMJより早期乳癌の女性に対して、術中の1回の標的型放射線治療と手術後に数回の通院を必要とする従来の放射線治療を比較した非劣勢RCT。術中1回の放射線治療は、術後通院放射線治療と比べ、5年の局所再発と長期生存率は非劣勢であることが示されまし…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @CochraneJapan: BMJより早期乳癌の女性に対して、術中の1回の標的型放射線治療と手術後に数回の通院を必要とする従来の放射線治療を比較した非劣勢RCT。術中1回の放射線治療は、術後通院放射線治療と比べ、5年の局所再発と長期生存率は非劣勢であることが示されまし…
RT @CochraneJapan: BMJより早期乳癌の女性に対して、術中の1回の標的型放射線治療と手術後に数回の通院を必要とする従来の放射線治療を比較した非劣勢RCT。術中1回の放射線治療は、術後通院放射線治療と比べ、5年の局所再発と長期生存率は非劣勢であることが示されまし…
BMJより早期乳癌の女性に対して、術中の1回の標的型放射線治療と手術後に数回の通院を必要とする従来の放射線治療を比較した非劣勢RCT。術中1回の放射線治療は、術後通院放射線治療と比べ、5年の局所再発と長期生存率は非劣勢であることが示されました。 https://t.co/gRqAULIUvZ
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
RT @ACTREC_TMC: Study published by @jsvaidya & colleagues in @bmj_latest suggests that a single dose of intraoperative radiotherapy may suf…
RT @vicatallah: Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es t…
Para la mayoría de las mujeres con cáncer de mama temprano, una sola dosis de radioterapia dirigida durante la cirugía es tan eficaz como la radioterapia convencional, sugieren hallazgos del ensayo clínico aleatorio TARGIT-A #VEA https://t.co/QS6jBO3T5Q
RT @DrLauraEsserman: An important step forward to reducing treatment burden for women with breast cancerSingle dose of radiation In the ope…
RT @eforgach: Resultados de Sobrevida y recurrencias en #cáncerdemama temprano tratado conservadoramente y #radioterapia intraoperatoria. #…
RT @DrLauraEsserman: An important step forward to reducing treatment burden for women with breast cancerSingle dose of radiation In the ope…
RT @ElenaSperk: Finally our long-term results are available....so happy to have them published. Check out here - open source 👇
RT @ElenaSperk: Finally our long-term results are available....so happy to have them published. Check out here - open source 👇
RT @Links_Medicus: Randomized trial: Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy du…
Study published by @jsvaidya & colleagues in @bmj_latest suggests that a single dose of intraoperative radiotherapy may suffice for some patients with breast cancer! Patients may not need to undergo weeks of RT! Food for thought and practice! https://t
Resultados de Sobrevida y recurrencias en #cáncerdemama temprano tratado conservadoramente y #radioterapia intraoperatoria. #BreastcancerMexico #Prosama #breastcancersurgeon https://t.co/4dWKoQ9P6e
RT @CroAviano: 🥼☢️ Tumore al seno, studio internazionale conferma l’efficacia della radioterapia intraoperatoria. Protagonista anche la Bre…